Dylan O’Brien Returns To Run The Maze For A “Death Cure” in February, 2017
20th Century Fox’s Maze Runner: The Death Cure is getting back on track as Deadline reports that cameras will again roll on the franchise sequel beginning in February. February 17, 2017 was originally planned to mark the film’s release date, but, following an on-set injury to leading man Dylan O’Brien earlier this year, production was halted to allow the star a full recovery. The movie should now hit the big screen January 12, 2018.
As with the previous two movies in the franchise, Maze Runner: The Death Cure is directed by Wes Ball from a screenplay by T.S. Nowlin, adapting the YA novels of James Dashner. It follows the events of 2014’s The Maze Runner and 2015’s Maze Runner: The Scorch Trials, and co-stars Thomas Brodie-Sangster, Rosa Salazar, Ki Hong Lee and Dexter Darden.
The Death Cure novel, which concludes the dystopian science fiction trilogy, is officially described as follows:
It’s the end of the line.
WICKED has taken everything from Thomas: his life, his memories, and now his only friends—the Gladers. But it’s finally over. The trials are complete, after one final test.
Will anyone survive?
What WICKED doesn’t know is that Thomas remembers far more than they think. And it’s enough to prove that he can’t believe a word of what they say.
The truth will be terrifying.
Thomas beat the Maze. He survived the Scorch. He’ll risk anything to save his friends. But the truth might be what ends it all.
The time for lies is over.
The new Death Cure release date will see the film open opposite the animated Gnomeo & Juliet sequel, Sherlock Gnomes.
Given the somewhat lackluster returns The Scorch Trials saw in the box office, is it actually worthwhile to go and conclude the film trilogy, especially since cast and crew went their separate ways after Dylan’s accident? Will you be seeing this movie anyway?
Your thoughts are important to us, so please leave a comment in the section below the article, and if this is your first time visiting please be sure to read the Privacy / Terms and Conditions Of Use.